The latest price target for ICU Medical (NASDAQ:ICUI) was reported by Keybanc on August 8, 2024. The analyst firm set a price target for $147.00 expecting ICUI to fall to within 12 months (a possible -8.80% downside). 8 analyst firms have reported ratings in the last year.

The latest analyst rating for ICU Medical (NASDAQ:ICUI) was provided by Keybanc, and ICU Medical maintained their overweight rating.

The last upgrade for ICU Medical Inc happened on June 17, 2024 when Raymond James raised their price target to $135. Raymond James previously had a market perform for ICU Medical Inc.

The last downgrade for ICU Medical Inc happened on November 8, 2022 when Raymond James changed their price target from N/A to N/A for ICU Medical Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of ICU Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for ICU Medical was filed on August 8, 2024 so you should expect the next rating to be made available sometime around August 8, 2025.

While ratings are subjective and will change, the latest ICU Medical (ICUI) rating was a maintained with a price target of $136.00 to $147.00. The current price ICU Medical (ICUI) is trading at is $161.19, which is out of the analyst’s predicted range.